Nureca Limited (NSE:NURECA)
India
· Delayed Price · Currency is INR 255.05
-0.85 (-0.33%)
May 28, 2025, 3:14 PM IST
Nureca Revenue
In the fiscal year ending March 31, 2025, Nureca had annual revenue of 1.10B INR with 19.29% growth. Nureca had revenue of 317.40M in the quarter ending March 31, 2025, with 87.04% growth.
Revenue
1.10B
Revenue Growth
+19.29%
P/S Ratio
2.33
Revenue / Employee
7.95M
Employees
138
Market Cap
2.55B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 211.46B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |
Nureca News
- 6 weeks ago - Nureca shares jump over 3% as Dr Trust & Dr Physio gear up to launch on Swiggy Instamart - Business Upturn
- 9 months ago - Nureca shares surge 6% after company signs distribution agreement - Business Upturn